Catalyst Wire Dossier Catalyst Wire Dossier

BMN165

· BioMarin Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMN165, covering 2019-07-12 to 2019-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU [Phase 3]

See pricing